Arends, M. (2018). Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: An international cohort study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationArends, M. Agalsidase Alfa Versus Agalsidase Beta for the Treatment of Fabry Disease: An International Cohort Study. BMJ Publishing Group, 2018.
MLA (9th ed.) CitationArends, M. Agalsidase Alfa Versus Agalsidase Beta for the Treatment of Fabry Disease: An International Cohort Study. BMJ Publishing Group, 2018.
Warning: These citations may not always be 100% accurate.